Biomarkers and digital tools
In collaborative work with the Computational Health Center, we are using cutting-edge methods in machine learning (ML) and AI for understanding and integrating multimodal medical datasets. This includes data from various sources such as randomised clinical trials, electronic health records, genomic biobanks, and more. Our research extends beyond clinical and genomic information, encompassing the exploration of additional variables to enhance our understanding of patients' disease states and progression. In multiple collaborations with large clinical research consortia, industry partners, and research institutions across different countries we are aiming for predicting patient outcomes, discover new biomarkers, forecast side effects, and enable personalised treatments tailored to individual patient needs.